Epibatidine

Drugs of the Future

Volumn 22, Issue 11, 1997, Pages 1210-1220

  Bai, Donglu ^a   Xu, Rui ^a   Zhu, Xingzu ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; EPIBATIDINE; MECAMYLAMINE; NICOTINIC RECEPTOR;

ANALGESIC ACTIVITY; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG SYNTHESIS; ENANTIOMER; IN VITRO STUDY; NONHUMAN; REACTION ANALYSIS; SHORT SURVEY;

EID: 0031469705     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (56)

1. For recent reviews on epibatidine see: (a) Broka, C.A. Synthetic approaches to epibatidine. Med Chem Res 1994, 4: 449-60. (b) Szántay, C., Kardos-Balogh, Z., Szántay, C. Jr. Epibatidine. In: The Alkaloids, Vol. 46, G.A. Cordell (Ed.), Academic Press, San Diego, 1995, 95-125. (c) Kellar, K.J. Epibatidine: Its pharmacological actions and utility for studying neuronal nicotinic receptors. Neurotransmissions 1995, 11: 1-5. (d) Sullivan, J.P., Bannon, A.W. Epibatidine: Pharmacological properties of a novel nicotinic acetylcholine receptor agonist and analgesic agent. CNS Drug Rev 1996, 2: 21-39. (e) Chen, Z., Trudell, M.L. Chemistry of 7-azabicyclo[2.2.1]hepta-2,5-dienes, 7-azabicyclo[2.2.1]hept-2-enes, and 7-azabicyclo[2.2.1]hepatanes. Chem Rev 1996, 96: 1179-93.
2. For recent reviews on epibatidine see: (a) Broka, C.A. Synthetic approaches to epibatidine. Med Chem Res 1994, 4: 449-60. (b) Szántay, C., Kardos-Balogh, Z., Szántay, C. Jr. Epibatidine. In: The Alkaloids, Vol. 46, G.A. Cordell (Ed.), Academic Press, San Diego, 1995, 95-125. (c) Kellar, K.J. Epibatidine: Its pharmacological actions and utility for studying neuronal nicotinic receptors. Neurotransmissions 1995, 11: 1-5. (d) Sullivan, J.P., Bannon, A.W. Epibatidine: Pharmacological properties of a novel nicotinic acetylcholine receptor agonist and analgesic agent. CNS Drug Rev 1996, 2: 21-39. (e) Chen, Z., Trudell, M.L. Chemistry of 7-azabicyclo[2.2.1]hepta-2,5-dienes, 7-azabicyclo[2.2.1]hept-2-enes, and 7-azabicyclo[2.2.1]hepatanes. Chem Rev 1996, 96: 1179-93.
3. For recent reviews on epibatidine see: (a) Broka, C.A. Synthetic approaches to epibatidine. Med Chem Res 1994, 4: 449-60. (b) Szántay, C., Kardos-Balogh, Z., Szántay, C. Jr. Epibatidine. In: The Alkaloids, Vol. 46, G.A. Cordell (Ed.), Academic Press, San Diego, 1995, 95-125. (c) Kellar, K.J. Epibatidine: Its pharmacological actions and utility for studying neuronal nicotinic receptors. Neurotransmissions 1995, 11: 1-5. (d) Sullivan, J.P., Bannon, A.W. Epibatidine: Pharmacological properties of a novel nicotinic acetylcholine receptor agonist and analgesic agent. CNS Drug Rev 1996, 2: 21-39. (e) Chen, Z., Trudell, M.L. Chemistry of 7-azabicyclo[2.2.1]hepta-2,5-dienes, 7-azabicyclo[2.2.1]hept-2-enes, and 7-azabicyclo[2.2.1]hepatanes. Chem Rev 1996, 96: 1179-93.
4. For recent reviews on epibatidine see: (a) Broka, C.A. Synthetic approaches to epibatidine. Med Chem Res 1994, 4: 449-60. (b) Szántay, C., Kardos-Balogh, Z., Szántay, C. Jr. Epibatidine. In: The Alkaloids, Vol. 46, G.A. Cordell (Ed.), Academic Press, San Diego, 1995, 95-125. (c) Kellar, K.J. Epibatidine: Its pharmacological actions and utility for studying neuronal nicotinic receptors. Neurotransmissions 1995, 11: 1-5. (d) Sullivan, J.P., Bannon, A.W. Epibatidine: Pharmacological properties of a novel nicotinic acetylcholine receptor agonist and analgesic agent. CNS Drug Rev 1996, 2: 21-39. (e) Chen, Z., Trudell, M.L. Chemistry of 7-azabicyclo[2.2.1]hepta-2,5-dienes, 7-azabicyclo[2.2.1]hept-2-enes, and 7-azabicyclo[2.2.1]hepatanes. Chem Rev 1996, 96: 1179-93.
5. For recent reviews on epibatidine see: (a) Broka, C.A. Synthetic approaches to epibatidine. Med Chem Res 1994, 4: 449-60. (b) Szántay, C., Kardos-Balogh, Z., Szántay, C. Jr. Epibatidine. In: The Alkaloids, Vol. 46, G.A. Cordell (Ed.), Academic Press, San Diego, 1995, 95-125. (c) Kellar, K.J. Epibatidine: Its pharmacological actions and utility for studying neuronal nicotinic receptors. Neurotransmissions 1995, 11: 1-5. (d) Sullivan, J.P., Bannon, A.W. Epibatidine: Pharmacological properties of a novel nicotinic acetylcholine receptor agonist and analgesic agent. CNS Drug Rev 1996, 2: 21-39. (e) Chen, Z., Trudell, M.L. Chemistry of 7-azabicyclo[2.2.1]hepta-2,5-dienes, 7-azabicyclo[2.2.1]hept-2-enes, and 7-azabicyclo[2.2.1]hepatanes. Chem Rev 1996, 96: 1179-93.
6. Spande, T.F., Garraffo, H.M., Edwards, M.W., Yeh, H.J.C., Pannel, L., Daly, J.W. Epibatidine: A novel (chloropyridyl)azabicycloheptane with potent analgesic activity from an Ecuadoran poison frog. J Amer Chem Soc 1992, 114: 3475-8.
7. Broka, C.A. Total synthesis of epibatidine. Tetrahedron Lett 1993, 34: 3251-4.
8. Fletcher, S.R., Baker, R., Chambers, M.S., Hobbs, S.C., Mitchell, P.J. The synthesis of (+)- and (-)-epibatidine. J Chem Soc Ser Chem Commun 1993, 1216-8.
9. Fletcher, S.R., Baker, R., Chambers, M.S., Herbert, R.H., Hobbs, S.C., Thomas, S.R., Verrier, H.M., Watt, A.P., Ball, R.G. Total synthesis and determination of the absolute configuration of epibatidine. J Org Chem 1994, 59: 1771-8.
10. Corey, E.J., Loh, T.E., Achyutha-Rao, S., Daley, D.C., Sarshar, S. Stereocontrolled total synthesis of (+)- and (-)-epibatidine. J Org Chem 1993, 58: 5600-2.
11. Szántay, C., Kardos-Balogh, Z., Moldvai, I., Szántay, C. Jr., Major-Temesváry, E., Blaskó, G. A practical route to epibatidine. Tetrahedron Lett 1994, 35: 3171-4.
12. Szántay, C., Kardos-Balogh, Z., Moldvai, I., Szántay, C. Jr., Major-Temesváry, E., Blaskó, G. A practical enantioselective synthesis of epibatidine. Tetrahedron 1996, 52: 11053-62.
13. Albertini, E., Barco, A., Benetti, S., De Risi, C., Pollini, G.P., Romagnoli, R., Zanirato, V. Total synthesis of (±)-epibatidine. Tetrahedron Lett 1994, 35: 9297-300.
14. Senokuchi, K., Nakai, H., Kawamura, M. et al. Synthesis and biological evaluation of (±)-epibatidine and the congeners. Synlett 1994, 343-4.
15. Sestanj, K., Melenski, E., Jirkovsky, I. Synthesis of epibatidine. Tetrahedron Lett 1994, 35: 5417-20.
16. Ko, S.Y., Lerpiniere, J., Linney, I.D., Wrigglesworth, R. The total synthesis of epibatidine. J Chem Soc Ser Chem Commun 1994, 1775-6.
17. Trost, B.M., Cook, G.R. An asymmetric synthesis of (-)-epibatidine. Tetrahedron Lett 1996, 37: 7485-8.
18. Albertini, E., Barco, A., Benetti, S., De Risi, C., Pollini, G.P., Zanirato, V. Enantioselective approach to 7-azabicyclo[2.2.1]heptane ring systems using D-(-)-quinic acid as the chiral educt: Application to the formal synthesis of (+)-epibatidine. Tetrahedron Lett 1997, 38: 681-4.
19. Hassner, A., Belostotskii, A.M. A simple method of preparation of 7-alkyl-7-azabicyclo[2.2.1]heptanes. Tetrahedron Lett 1995, 36: 1709-12.
20. Davis, C.R., Johnson, R.A., Cialdella, J.I., Liggett, W.F., Mizsak, S.A., Marshall, V.P. Microbiological oxygenation of bridgehead azabicycloalkanes. J Org Chem 1997, 62: 2244-51.
21. Huang, D.F., Shen, T.Y. A versatile total synthesis of epibatidine and analogs. Tetrahedron Lett 1993, 34: 4477-80.
22. Kotian, P.L., Carrol, F.I. Synthesis of (+) and (-) epibatidine. Synth Commun 1995, 25: 63-71.
23. Clayton, S.C., Regan, A.C. A total synthesis of (±)-epibatidine. Tetrahedron Lett 1993, 34: 7493-6.
24. Okabe, K., Natsume, M. Total synthesis of a frog poison, (±)-epibatidine, a potent non-opioid analgesic. Chem Pharm Bull 1994, 42: 1432-6.
25. Zhang, C., Trudell, M.L. A short and efficient total synthesis of (±)-epibatidine. J Org Chem 1996, 61: 7189-91.
26. Pandey, G., Bagul, T.D., Lakshmaiah, G. An expeditious synthesis of epibatidine and analogues. Tetrahedron Lett 1994, 35: 7439-42.
27. Xu, R., Chu, G., Bai, D. Total synthesis of (±)-epibatidine. Tetrahedron Lett 1996, 37: 1463-6.
28. Bai, D., Xu, R., Chu, G., Zhu, X. Synthesis of (±)-epibatidine and its analogues. J Org Chem 1996, 61: 4600-6.
29. Hernández, A., Marcos, M., Rapoport, H. Synthesis of (+)- and (-)-N-BOC-7-azabicyclo[2.2.1]heptan-2-ones, versatile intermediates for the enantiospecific synthesis of (+)- and (-)-epibatidine and analogues. J Org Chem 1995, 60: 2638-91.
30. Li, T., Qian, C., Eckman, J., Huang, D.F., Shen, T.Y. The analgesic effect of epibatidine and isomers. Bioorg Med Chem Lett 1993, 3: 2759-64.
31. Qian, C., Li, T., Shen, T.Y., Libertine-Garahan, L., Eckman, J., Biftu, T., Ip, S. Epibatidine is a nicotinic analgesic. Eur J Pharmacol 1993, 250: R13-4.
32. Damaj, M.J., Creasy, K.R., Grove, A.D., Rosecrans, J.A., Martin, B.R. Pharmacological effects of epibatidine optical enantiomers. Brain Res 1994, 664: 34-40.
33. Rao, T.S., Correa, L.D., Reid, R.T., Lloyd, G.K. Evaluation of anti-nociceptive effects of neuronal nicotinic acetylcholine receptor (nAChR) ligands in the rat tail-flick assay. Neuropharmacology 1996, 35: 393-405.
34. Sullivan, J.P., Briggs, C.A., Donnelly, D. et al. (+)-Epibatidine can differentially evoke responses mediated by putative subtypes of nicotinic acetylcholine receptors (nAChRs). Med Chem Res 1994, 4: 502-16.
35. Sullivan, J.P., Decker, M.W., Brioni, J.D. et al. (+)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J Pharmacol Exp Ther 1994, 271: 624-31.
36. Badio, B., Daly, J.W. Epibatidine, a potent analgetic and nicotinic agonist. Mol Pharmacol 1994, 45: 562-9.
37. Badio, B., Garraffo, H.M., Spande, T.F., Daly, J.W. Epibatidine: Discovery and definition as a potent analgesic and nicotinic agonist. Med Chem Res 1994, 4: 440-8.
38. Bannon, A.W., Gunther, K.L., Decker, M.W. Is epibatidine really analgesic? Dissociation of the locomotor activity, temperature, and analgesic effects of (+)-epibatidine. Pharmacol Biochem Behav 1995, 51: 693-8.
39. Bannon, A.W., Gunther, K.L., Decker, M.W., Arneric, S.P. The influence of Bay K 8644 treatment on (+)-epibatidine-induced analgesia. Brain Res 1995, 678: 244-50.
40. Rupniak, N.M.J., Patel, S., Marwood, R., Webb, J., Traynor, J.R., Elliott, J., Freedman, S.B., Fletcher, S.R., Hill, R.G. Antinociceptive and toxic effects of (+)-epibatidine oxalate attributable to nicotinic agonist activity. Brit J Pharmacol 1994, 113: 1487-93.
41. Bonhaus, D.W., Bley, K.R., Broka, C.A., Fontana, D.J., Leung, E., Lewis, R., Shieh, A., Wong, E.H. Characterization of the electrophysiological, biochemical and behavioral actions of epibatidine. J Pharmacol Exp Ther 1995, 272: 1199-203.
42. Damaj, M.I., Tucker, S.M., Aceto, M.D., Martin, B.R. Analgesic activity of epibatidine and its enantiomers in a chemical model of pain in mice. Med Chem Res 1994, 4: 483-92.
43. Damaj, M.I., Martin, B.R. Tolerance to the antinociceptive effect of epibatidine after acute and chronic administration in mice. Eur J Pharmacol 1996, 300: 51-7.
44. Levin, E.D., Toll, K., Chang, G., Christopher, N.C., Briggs, S.J., Fiedler, W. Epibatidine, a potent nicotinic agonist: Effects on learning and memory in the radial-arm maze. Med Chem Res 1996, 543-4.
45. Role, L.W., Berg, D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron 1996, 16: 1077-85.
46. 3H]-epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol Pharmacol 1995, 48: 280-7.
47. 3H]-Epibatidine labels nicotinic receptors in rat brain: An autoradiographic study. J Pharmacol Exp Ther 1995, 275: 1030-4.
48. Scheffel, U., Taylor, G.F., Kepler, J.A., Carroll, F.I., Kuhar, M.J. In vivo labeling of neuronal nicotinic acetylcholine receptors with radiolabeled isomers of norchloroepibatidine. NeuroReport 1995, 6: 2483-8.
49. Ding, Y.S., Gatley, S.J., Fowler, J.S., Volkow, N.D., Aggarwal, F., Logan, J., Dewey, S.L., Liang, F., Carroll, F.I., Kuhar, M.J. Mapping nicotinic acetylcholine receptors with PET. Synapse 1996, 24: 403-7.
50. +efflux from mouse thalamic synaptosomes. J Pharmacol Exp Ther 1996, 277: 1383-96.
51. Sullivan, J.P., Monteggia, L.M., Anderson, D.J., Giordano, T.G., Arneric, S.P., Gopalakrishnan, M. Stable expression and pharmacologic properties of the human neuronal nicotinic acetylcholine receptor α-4 β-2 subtype. FASEB J 1995, 9: S2262.
52. Wilkie, G.I., Hutson, P., Sullivan, J.P., Wonnacott, S. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem Res 1996, 21: 1141-8.
53. Sacaan, A.I., Menzaghi, F., Dunlop, J.L., Correa, L.D., Whelan, K.T., Lloyd, G.K. Epibatidine, a nicotinic acetylcholine receptor agonist releases monoaminergic neurotransmitters: In vitro and in vivo evidence in rats. J Pharmacol Exp Ther 1996, 276: 509-15.
54. Khan, I.M., Marsala, M., Printz, M.P., Taylor, P., Yaksh, T.L. Intrathecal nicotinic agonist-elicited release of excitatory amino acids as measured by in vivo spinal microdialysis in rats. J Pharmacol Exp Ther 1996, 278: 97-106.
55. Daly, J.W., Spande, T.F., Garraffo, H.M. (Dept. Health Human Services [USA]). Epibatidine and derivs., compsns. and methods of treating pain. EP 629200, JP 95505149, US 5314899, WO 9318037.
56. Quian, C., Li, T., Biftu, T., Shen, T.-Y. (Univ. Virginia; CytoMed, Inc.). Epibatidine and derivs. thereof as cholinergic receptor agonists and antagonists. EP 717623, WO 9507078.